Purple Biotech Stock Alpha and Beta Analysis
| PPBT Stock | USD 3.25 0.11 3.27% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Purple Biotech. It also helps investors analyze the systematic and unsystematic risks associated with investing in Purple Biotech over a specified time horizon. Remember, high Purple Biotech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Purple Biotech's market risk premium analysis include:
Beta 1 | Alpha 0.67 | Risk 21.45 | Sharpe Ratio 0.0735 | Expected Return 1.58 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Purple |
Purple Biotech Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Purple Biotech market risk premium is the additional return an investor will receive from holding Purple Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Purple Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Purple Biotech's performance over market.| α | 0.67 | β | 1.00 |
Purple Biotech expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Purple Biotech's Buy-and-hold return. Our buy-and-hold chart shows how Purple Biotech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Purple Biotech Market Price Analysis
Market price analysis indicators help investors to evaluate how Purple Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Purple Biotech shares will generate the highest return on investment. By understating and applying Purple Biotech stock market price indicators, traders can identify Purple Biotech position entry and exit signals to maximize returns.
Purple Biotech Return and Market Media
The median price of Purple Biotech for the period between Sat, Nov 2, 2024 and Fri, Jan 31, 2025 is 3.61 with a coefficient of variation of 26.53. The daily time series for the period is distributed with a sample standard deviation of 0.97, arithmetic mean of 3.66, and mean deviation of 0.66. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24 Associated with 79 percent Reduction in Risk of Death | 11/04/2024 |
2 | Purple Biotech Reports Positive Final Results from Randomized Phase 2 Study of CM24 in Second ... | 12/02/2024 |
3 | Purple Biotech Announces 2.8 Million Registered Direct Offering of American Depositary Shares | 12/03/2024 |
4 | Purple Biotech Announces Closing of 2.8 Million Registered Direct Offering of American Depositary Shares | 12/05/2024 |
5 | Purple Biotech Expands ATM Offering by 1.33 Million - MSN | 01/08/2025 |
About Purple Biotech Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Purple or other stocks. Alpha measures the amount that position in Purple Biotech has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 (projected) | Dividend Yield | 0.1 | 0.088 | Price To Sales Ratio | 118.74 | 84.89 |
Purple Biotech Upcoming Company Events
As portrayed in its financial statements, the presentation of Purple Biotech's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Purple Biotech's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Purple Biotech's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Purple Biotech. Please utilize our Beneish M Score to check the likelihood of Purple Biotech's management manipulating its earnings.
| 14th of February 2024 Upcoming Quarterly Report | View | |
| 21st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Purple Biotech
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Purple Stock Analysis
When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.